3-chloro-4-ethylthioaniline | 19284-90-3

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 3-chloro-4-ethylthioaniline
• 英文别名: 3-Chloro-ethylthioanilin；3-Chloro-4-ethylsulfanyl-phenylamine；3-chloro-4-ethylsulfanylaniline
• CAS: 19284-90-3
• 化学式: C₈H₁₀ClNS
• 分子量: 187.693
• InChiKey: LNXLUAQFYHQATK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  51.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-chloro-4-ethylthioaniline 以 氯苯 为溶剂， 生成 N-(3-Chloro-4-ethylsulfanyl-phenyl)-2-methyl-butyramide
  参考文献：
  名称：

  GB1141183

  摘要：

  公开号：

文献信息

• Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists
  作者：Steven M. Bromidge、Steven Dabbs、David T. Davies、Susannah Davies、D.Malcolm Duckworth、Ian T. Forbes、Angela Gadre、Peter Ham、Graham E. Jones、Frank D. King、Damian V. Saunders、Kevin M. Thewlis、Deepa Vyas、Thomas P. Blackburn、Vicky Holland、Guy A. Kennett、Graham J. Riley、Martyn D. Wood

  DOI：10.1016/s0968-0896(99)00228-x

  日期：1999.12

  antagonists have been prepared by rapid parallel synthesis. These N-substituted phenyl-N'-pyridin-3-yl ureas were found to have a range of 5-HT2C receptor affinities and selectivities over the closely related 5-HT2A receptor. Extrapolation of simple SAR, derived from this set of compounds, to the more active but synthetically more complex 1-(3-pyridylcarbamoyl)indoline series allowed us to target optimal

  已经通过快速平行合成制备了一系列的5-HT 2C拮抗剂模型。发现这些N-取代的苯基-N'-吡啶-3-基脲比密切相关的5-HT2A受体具有一系列的5-HT2C受体亲和力和选择性。从这组化合物中衍生出的简单SAR外推至活性更高但合成上更复杂的1-（3-吡啶基氨基甲酰基）二氢吲哚系列，使我们能够靶向最佳取代模式并鉴定有效和选择性的5-HT（2C / 2B）拮抗剂。
• [EN] INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS<br/>[FR] DERIVES INDOLINIQUES UTILISES COMME ANTAGONISTES DE 5HT2C
  申请人：SMITHKLINE BEECHAM PLC

  公开号：WO1995001976A1

  公开（公告）日：1995-01-19

  (EN) A compound of formula (I) or a salt thereof, wherein: P represents phenyl, a quinoline or isoquinoline residue, or a 5-membered or 6-membered aromatic heterocyclic ring containing up to three heteroatoms selected from nitrogen, oxygen or sulphur; R1 is hydrogen, C1-6 alkyl, halogen, CF3, NR7R8 or OR9 where R7, R8 and R9 are independently hydrogen, C1-6 alkyl or arylC1-6alkyl; R2 is hydrogen or C1-6 alkyl; R3 is C1-6 alkyl; n is 0 to 3; m is 0 to 4; and R4 groups are independently C1-6 alkyl optionally substituted by one or more halogen atoms, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C3-6 cycloalkylC1-6 alkyl, C1-6 alkylthio, C3-6cycloalkylthio, C3-6 cycloalkylC1-6 alkylthio, halogen, nitro, CF3, OCF3, SCF3, SO2CF3, SO2F, formyl, C2-6 alkanoyl, cyano, optionally substituted phenyl or thienyl, NR7R8, CONR7R8, or OR9 where R7, R8 and R9 are as defined for R1, CO2R10 where R10 is hydrogen or C1-6 alkyl. The compounds have 5HT2C receptor antagonist activity. Certain compounds of the invention also exhibit 5HT2B antagonist activity. 5HT2C/2B receptor antagonists are believed to be of potential use in the treatment of CNS disorders.(FR) Composé répondant à la formule (I) ou son sel. Dans ladite formule, P représente phényle, un reste de quinoléine ou d'isoquinoléine, ou un hétérocycle aromatique à 5 ou 6 chaînons renfermant jusqu'à trois hétéroatomes choisis parmi azote, oxygène ou soufre; R1 représente hydrogène, alkyle C1-6, halogène, CF3, NR7R8 ou OR9 où R7, R8 et R9, indépendamment les uns des autres, représentent hydrogène, alkyle C1-6, ou arylalkyle C1-6; R2 représente hydrogène ou alkyle C1-6; R3 représente alkyle C1-6; n est compris entre 0 et 3; m est compris entre 0 et 4; et chaque groupe R4 représente alkyle C1-6 éventuellement substitué par un ou plusieurs atomes d'halogène, alcényle C2-6, alcynyle C2-6, cycloalkyle C3-6, cycloalkyle C3-6-alkyle C1-6, alkylthio C1-6, cycloalkylthio C3-6, cycloalkyle C3-6- alkylthio C1-6, halogène, nitro, CF3, OCF3, SCF3, SO2CF3, SO2F, formyle, alcanoyle C2-6, cyano, phényle ou thiényle éventuellement substitué, NR7R8, CONR7R8 ou OR9 où R7, R8 et R9 ont les mêmes notations que pour R1, CO2R10 où R10 représente hydrogène ou alkyle C1-6. Ces composés présentent une activité d'antagoniste du récepteur de 5HT2C. Certains de ces composés présentent également une activité d'antagoniste de 5HT2B. On pense que les antagonistes des récepteurs de 5HT2C/2B pourraient s'avérer utiles dans le traitement des troubles du système nerveux central.

  化合物式（I）或其盐，其中：P代表苯基，喹啉或异喹啉残基，或者包含最多三个氮、氧或硫杂原子的五元或六元芳香杂环环；R1为氢，C1-6烷基，卤素，CF3，NR7R8或OR9，其中R7、R8和R9独立地为氢，C1-6烷基或芳基C1-6烷基；R2为氢或C1-6烷基；R3为C1-6烷基；n为0至3；m为0至4；R4基独立地为C1-6烷基，可选地被一个或多个卤素原子取代，C2-6烯基，C2-6炔基，C3-6环烷基，C3-6环烷基C1-6烷基，C1-6烷基硫，C3-6环烷基硫，C3-6环烷基C1-6烷基硫，卤素，硝基，CF3，OCF3，SCF3，SO2CF3，SO2F，甲酰基，C2-6酰基，氰基，可选地取代的苯基或噻吩基，NR7R8，CONR7R8或OR9，其中R7、R8和R9如R1所定义，CO2R10其中R10为氢或C1-6烷基。这些化合物具有5HT2C受体拮抗活性。该发明的某些化合物还表现出5HT2B受体拮抗活性。5HT2C/2B受体拮抗剂被认为具有在中枢神经系统疾病治疗中的潜在用途。
• [EN] THIOUREA INHIBITORS OF HERPES VIRUSES<br/>[FR] THIO-UREES INHIBITRICES DES VIRUS DE L'HERPES
  申请人：AMERICAN HOME PROD

  公开号：WO2000034268A1

  公开（公告）日：2000-06-15

  Compounds of formula (I) wherein A is heteroaryl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; W is O, NR6, or is absent; G is aryl or heteroaryl; and X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; and J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or a pharmaceutical salt thereof, useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.

  化合物的式子（I），其中A是杂环芳基；R9-R12独立地是氢，1到4个碳原子的烷基，1到4个碳原子的全氟烷基，卤素，1到4个碳原子的烷氧基，或氰基，或者R9和R10或R11和R12可以结合成5到7个碳原子的芳基；W是O，NR6，或不存在；G是芳基或杂环芳基；X是键，-NH，1到6个碳原子的烷基，1到6个碳原子的烯基，1到6个碳原子的烷氧基，1到6个碳原子的硫代烷基，1到6个碳原子的烷基氨基，或（CH）J；J是1到6个碳原子的烷基，3到7个碳原子的环烷基，苯基或苄基；n是1到6的整数；或其药用盐，用于治疗与疱疹病毒相关的疾病，包括人类巨细胞病毒，单纯疱疹病毒，埃普斯坦-巴尔病毒，水痘-带状疱疹病毒，人类疱疹病毒6和7，以及卡波西疱疹病毒。
• [EN] THIOUREA INHIBITORS OF HERPES VIRUSES<br/>[FR] INHIBITEURS DE THIO-UREE DES VIRUS DE L'HERPES
  申请人：AMERICAN HOME PROD

  公开号：WO2000034269A1

  公开（公告）日：2000-06-15

  Compounds of formula (1) wherein, R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6,-COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z; or R2 and R3 or R3 and R4, taken together from a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; A is heteroaryl; W is O, NR6, or is absent; Y is -(CO)- or -(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) or phenyl; G is aryl or heteroaryl; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpes viruses -6 and -7, and Kaposi herpesvirus.

  式子（1）的化合物，其中R1-R5独立地选择自氢、1至6个碳原子的烷基、2至6个碳原子的烯基、2至6个碳原子的炔基、1至6个碳原子的全氟烷基、3至10个碳原子的环烷基、3至10个碳原子的杂环烷基、芳基、杂芳基、卤素、-CN、-NO2、-CO2R6、-COR6、-OR6、-SR6、-SOR6、-SO2R6、-CONR7R8、-NR6N（R7R8）、-N（R7R8）或W-Y-(CH2)n-Z;或R2和R3或R3和R4，一起来自3至7个成员的杂环烷基或3至7个成员的杂芳基;R6和R7独立地为氢、1至6个碳原子的烷基、1至6个碳原子的全氟烷基或芳基;R8为氢、1至6个碳原子的烷基、1至6个碳原子的全氟烷基、3至10个碳原子的环烷基、3至10个成员的杂环烷基、芳基或杂芳基，或R7和R8一起可以形成3至7个成员的杂环烷基;A为杂芳基;W为O、NR6或不存在;Y为-(CO)-或-(CO2)-，或不存在;Z为1至4个碳原子的烷基、-CN、-CO2R6、COR6、-CONR7R8、-OCOR6、-NR6COR7、-OCONR6、-OR6、-SR6、-SOR6、-SO2R6、SR6N（R7R8）、-N（R7R8）或苯基;G为芳基或杂芳基;X为键、-NH、1至6个碳原子的烷基、1至6个碳原子的烯基、1至6个碳原子的烷氧基、1至6个碳原子的硫代烷基、1至6个碳原子的烷基氨基或（CH）J;J为1至6个碳原子的烷基、3至7个碳原子的环烷基、苯基或苄基; n为1至6的整数;在治疗与疱疹病毒相关的疾病中有用，包括人类巨细胞病毒、单纯疱疹病毒、EB病毒、水痘-带状疱疹病毒、人类疱疹病毒-6和-7以及卡波西疱疹病毒。
• Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
  申请人：American Home Products Corporation

  公开号：US20010039348A1

  公开（公告）日：2001-11-08

  Compounds having the formula: 1 wherein R 1 -R 5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, —CN, —NO 2 , —CO 2 R 6 , —COR 6 , —OR 6 , —SR 6 , —SOR 6 , —SO 2 R 6 , —CONR 7 R 8 , —NR 6 N(R 7 R 8 ), —N(R 7 R 8 ) or W-Y-(CH 2 ) n -Z provided that at least one of R 1 -R 5 is not hydrogen; or R 1 and R 2 or R 3 and R 4 , taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R 6 and R 7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R 8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R 7 and R 8 , taken together may form a 3 to 7 membered heterocycloalkyl; W is O, NR 6 , or is absent; Y is —(CO)— or —(CO 2 )—, or is absent; Z is alkyl of 1 to 4 carbon atoms, —CN, —CO 2 R 6 , COR 6 , —CONR 7 R 8 , —OCOR 6 , —NR 6 COR 7 , —OCONR 6 , —OR 6 , —SR 6 , —SOR 6 , —SO 2 R 6 , SR6N(R7R8), —N(R 7 R 8 ) or phenyl; G is aryl or fused bicyclic heteroaryl; X is a bond, —NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.

  化合物的化学式为1，其中R1-R5独立选择自氢、1到6个碳原子的烷基、2到6个碳原子的烯基、2到6个碳原子的炔基、1到6个碳原子的全卤烷基、3到10个碳原子的环烷基、3到10个碳成员的杂环烷基、芳基、杂芳基、卤素、-CN、-NO2、-CO2R6、-COR6、-OR6、-SR6、-SOR6、-SO2R6、-CONR7R8、-NR6N（R7R8）、-N（R7R8）或W-Y-（CH2）n-Z，其中至少一个R1-R5不是氢；或R1和R2或R3和R4，一起形成3到7个成员的杂环烷基或3到7个成员的杂芳基；R6和R7独立地为氢、1到6个碳原子的烷基、1到6个碳原子的全卤烷基或芳基；R8为氢、1到6个碳原子的烷基、1到6个碳原子的全卤烷基、3到10个碳原子的环烷基、3到10个成员的杂环烷基、芳基或杂芳基，或R7和R8一起形成3到7个成员的杂环烷基；W为O、NR6或不存在；Y为-CO-或-CO2-，或不存在；Z为1到4个碳原子的烷基、-CN、-CO2R6、COR6、-CONR7R8、-OCOR6、-NR6COR7、-OCONR6、-OR6、-SR6、-SOR6、-SO2R6、SR6N（R7R8）、-N（R7R8）或苯基；G为芳基或融合的双环杂芳基；X为键、-NH、1到6个碳原子的烷基、1到6个碳原子的烯基、1到6个碳原子的烷氧基、1到6个碳原子的硫代烷基、1到6个碳原子的烷基氨基或（CH）J；J为1到6个碳原子的烷基、3到7个碳原子的环烷基、苯基或苄基；n为1到6的整数。该化合物可用于治疗与疱疹病毒相关的疾病，包括人类巨细胞病毒、单纯疱疹病毒、EB病毒、水痘-带状疱疹病毒、人类疱疹病毒-6和-7以及卡波西疱疹病毒。